Portfolio News

Allay Therapeutics Announces $57.5M Series D Financing and Venture Debt Line to Advance ATX101 and its Ultra-Sustained Pain Platform for Post-Surgical Pain Management

June 5, 2025

|

Other News & Insights

Discover more news and insights from us.

Stay up to date with the latest news, insights, and updates. Explore more stories and stay informed with our latest insights.